Lhasa Limited shared knowledge shared progress
Home > Library > Search the Library > (Q)SAR Evaluation of Drug Impurities from the US FDA Scientific Perspective
Publications

(Q)SAR Evaluation of Drug Impurities from the US FDA Scientific Perspective

pdf fileKruhlak NL;

This presentation was given by Dr Naomi Kruhlak, at the 2019 Pharmaceutical Industry and Regulators Symposium, in Brazil.

Download
  • Linked In
  • Twitter
ISO 9001 Certified Queen's Award 2016 Queen's Award 2017

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.